Progressive gait and balance difficulties, and associated falls, are among the most common levodopa resistant symptoms in Parkinson disease (PD), eventually occurring in nearly all patients. During the current funding period, U-M Udall Center research demonstrated a far more prominent, dynamic and multifaceted role for cholinergic signaling in PD gait abnormalities than previously appreciated. These insights position us to establish a systems neuroscience model of circuit interactions in gait by pursuing an interrelated and complementary set of clinical and basic studies, and to perform the first prospective assessment of cholinergic deficits as a biomarker of clinical heterogeneity in PD. Considerable data, including that developed during the current funding period, demonstrates that normal gait and posture depend on integration of sensory-attentional and motor information, and that cholinergic neurotransmission is vital for normal ?attentional-motor? interface at multiple CNS sites. These data support a novel, mechanistic model of attentional-motor interactions that will be tested with the studies proposed. Project I will dissect, in a rodent model, the role of cholinergic neurotransmission in detecting, transferring, and integrating attentional information as it traverses corticostriatal circuits. Opto- and chemo-genetic strategies will be used to test whether enhancing cortical or striatal cholinergic neurotransmission can reduce fall propensity in the ?Dual Lesion? (DL) rodent model of PD falls. Project II will employ the cholinergic PET ligand [18F]FEOBV in PD subjects to test the hypothesis that specific regional patterns of cholinergic dysfunction associate with distinct PD gait abnormalities, including falls and freezing of gait. Combined with Project I, this work has the potential to establish striatal cholinergic interneurons as an essential mediator of PD gait dysfunction. Project III will assess occipital cortical cholinergic denervation in PD subjects as an early, pathologic biomarker of later gait and cognitive decline. Projects II and III will take advantage of the uniquely valuable PD subject cohort established during the original funding period, and together constitute a first step toward the development of novel PD stratification tools. The U-M Udall Center will collaborate with members of the Pacific and University of Rochester Udall Centers, and be supported by Administrative, Clinical Resource, Neuroimaging Resource and Biostatistics and Data Management Cores. The Administrative Core is strongly committed to and will direct education of PD researchers, PD patients, and their families. Together, our innovative approaches will advance the goal of the NINDS Udall Centers of Excellence program to ?define the causes of and discover improved treatments for PD.? No other current Udall Center is focused on gait and postural abnormalities in PD, on cholinergic deficits, or on use of a pathological biomarker to define PD subgroups. The proposed U-M Udall Center will continue to play a unique and important role within the Udall Centers program.

Public Health Relevance

Up to 70% of patients with Parkinson disease fall each year, quadrupling the rate of hip fractures, leading to extended hospitalizations, increased use of skilled nursing facilities and eventual nursing home placement. University of Michigan scientists have developed breakthrough evidence that these falls, which are resistant to currently available treatments, arise from the degeneration of brain cells that use the neurochemical acetylcholine. By integrating neuroimaging, behavioral and pharmacological studies in patients with Parkinson?s disease and in animal models, we aim to further dissect the relationship between falls and abnormalities in these brain cells, and to identify early clinical features that reflect cholinergic dysfunction and identify a subtype of Parkinson disease with a more aggressive future course.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS091856-06
Application #
9849375
Study Section
Special Emphasis Panel (ZNS1)
Program Officer
Sieber, Beth-Anne
Project Start
2014-09-30
Project End
2020-08-31
Budget Start
2019-09-18
Budget End
2020-08-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Neurology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Rektor, Ivan; Bohnen, Nicolaas I; Korczyn, Amos D (2018) Subtype definition of vascular parkinsonism. Parkinsonism Relat Disord 52:107-108
Dinov, Ivo D; Palanimalai, Selvam; Khare, Ashwini et al. (2018) Randomization-Based Statistical Inference: A Resampling and Simulation Infrastructure. Teach Stat 40:64-73
Antoniou, Nasia; Vlachakis, Dimitrios; Memou, Anna et al. (2018) A motif within the armadillo repeat of Parkinson's-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway. Sci Rep 8:3455
Bohnen, Nicolaas I; Muller, Martijn (2018) Reader response: Odor identification as a biomarker of preclinical AD in older adults at risk. Neurology 90:343
Sarter, Martin; Phillips, Kyra B (2018) The neuroscience of cognitive-motivational styles: Sign- and goal-trackers as animal models. Behav Neurosci 132:1-12
Kim, Kamin; Bohnen, Nicolaas I; Müller, Martijn L T M et al. (2018) Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease. Neuroimage :
Miller, Nathaniel S; Chou, Kelvin L; Bohnen, Nicolaas I et al. (2018) Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease. Parkinsonism Relat Disord 48:54-60
Kalinin, Alexandr A; Allyn-Feuer, Ari; Ade, Alex et al. (2018) 3D Shape Modeling for Cell Nuclear Morphological Analysis and Classification. Sci Rep 8:13658
Beaulieu, Mélanie L; Müller, Martijn L T M; Bohnen, Nicolaas I (2018) Peripheral neuropathy is associated with more frequent falls in Parkinson's disease. Parkinsonism Relat Disord 54:46-50
Bohnen, Nicolaas I; Teipel, Stefan J (2018) Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes. Neurology 90:823-824

Showing the most recent 10 out of 100 publications